Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-19-036009

Chief Financial Officer bought 2,500 shares at $4.33 ($10,825)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Notman Donald Chief Financial Officer 2019-06-14 Purchase +2,500 $4.33 $10,825 24,049 D: show line 1 in the form
Open-market purchases · 2,500 sh · avg $4.33 · $10,825
Loading xslF345X03/a4.xml…